06-25-2008, 04:58 PM
|
#1
|
|
Senior Member
Join Date: Feb 2005
Location: Wisconsin
Posts: 159
|
Thank you so much to each of you for your kind thoughts and words! I am expecting that the surgery will go very well and that the pathology will show no need for further treatment -- other than continuing the quarterly Herceptin. I may consider doing the Herceptin every three weeks again for awhile if the pathology shows that these cells are also Her2+. We'll see. I also may take another look at Tykerb.
And no, the insurance company didn't balk at the quarterly Herceptin. I am a member of a wonderful local HMO (and the last two years I have also worked there :-) But the first time I went though this I didn't work there and they were wonderful then too.
Val
__________________
BLOG:
http://valleygirlvnp.blogspot.com/
Dx 11/04, Age 42, ER-/PR-, HER2+++
3 months weekly Herceptin, Taxol. Carboplatin
Significant tumor shrinkage
Mastectomy 3/05; Stage 3b, 9 cm tumor, 5/8+ nodes
3 more months weekly Herceptin, Taxol. Carboplatin
7/05 30 radiation treatments, IMRT planning approach
Started 1 year of Herceptin 9/05
9/06 Began quarterly triple doses Herceptin. Brain & breast MRIs semi annually.
* * * * * * * * * * * * * * * * * * * * * * * * * * *
6/08 Right breast, intraductal carcinoma, high nuclear grade associated with comedo necrosis; extensive diffusely involved the entire biopy specimen. ER+, PR-, Her2 unknown at this point, 07/08 mastectomy.
|
|
|
Hybrid Mode
